Sarepta Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC SRPT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

266,549

Value ($000)

5,736

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,736	0.0%	266,549	12/31/2025
2025 Q3	11/14/2025	4,499	0.0%	233,461	9/30/2025
2025 Q2	8/14/2025	6,774	0.0%	396,167	6/30/2025
2025 Q1	5/19/2025	29,570	0.0%	463,342	3/31/2025
2024 Q4	2/14/2025	36,392	0.0%	299,301	12/31/2024
2024 Q3	11/14/2024	33,496	0.0%	268,203	9/30/2024
2024 Q2	8/14/2024	47,634	0.0%	301,481	6/30/2024
2024 Q1	5/15/2024	20,847	0.0%	161,027	3/31/2024
2023 Q4	2/14/2024	15,526	0.0%	161,012	12/31/2023
2023 Q3	11/13/2023	19,538	0.0%	161,182	9/30/2023
2023 Q2	8/11/2023	21,596	0.0%	156,689	6/30/2023
2023 Q1	5/15/2023	21,596	0.0%	156,689	3/31/2023
2022 Q4	2/14/2023	15,721	0.0%	121,321	12/31/2022
2022 Q3	11/14/2022	13,272	0.0%	120,067	9/30/2022
2022 Q2	8/12/2022	10,382	0.0%	138,507	6/30/2022
2022 Q1	5/16/2022	10,745	0.0%	137,545	3/31/2022
2021 Q4	2/14/2022	14,835	0.0%	164,746	12/31/2021
2021 Q3	11/15/2021	9,441	0.0%	102,091	9/30/2021
2021 Q2	8/16/2021	8,685	0.0%	111,723	6/30/2021
2021 Q1	5/14/2021	15,282	0.0%	205,042	3/31/2021
2020 Q4	3/1/2021	69,314	0.0%	406,555	12/31/2020
2020 Q3	11/13/2020	55,593	0.0%	395,879	9/30/2020
2020 Q2	8/14/2020	63,421	0.0%	395,539	6/30/2020
2020 Q1	5/15/2020	44,592	0.0%	455,859	3/31/2020
2019 Q4	2/14/2020	58,258	0.0%	451,473	12/31/2019